Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Genomic imprinting wikipedia , lookup
Site-specific recombinase technology wikipedia , lookup
Gene therapy of the human retina wikipedia , lookup
Polycomb Group Proteins and Cancer wikipedia , lookup
Mir-92 microRNA precursor family wikipedia , lookup
Embryonic Stem Cells in Primates by Parthenogenesis Graduate Studies Department of Physiology MICHIGAN STATE UNIVERSITY Jose Cibelli, Ph.D. Biparental primate embryonic stem (ES) cells have the potential to become any cell type of the adult body. We have recently created parthenogenetic non-human primate ES cells (Cyno-1) from a Cynomolgus macaque female. Teratomas from these cells differentiate preferentially to ectoderm and endoderm-derived cells. Mesoderm derived cells are present only in limited numbers. By definition these cells lack any paternal contribution to their genome, thus it is likely that their imprinting status significantly differs from biparental ES cell lines and is presumably responsible for their altered differentiation capacity in comparison to biparental cells. The long-term goal of our work is to understand the differentiation processes that occur in parthenogenetic ES cells. Our studies are directed at the overall patterns of gene expression and how they change as differentiation occurs. We are comparing global gene expression patterns of undifferentiated and differentiated Cyno-1 cells with that of primate embryonic stem cells derived from fertilized embryos, with particular emphasis on the role of imprinted genes. This information will help us understand phenotypic differences in monoparental and biparental primate ES cells and gene expression cascades associated with cell differentiation that are potentially influenced by imprinting status. Figure 1 To date, parthenogenetic ES cells are the only source of autologous ES cells known in non-human primates. We have shown that these cells are capable of producing a variety of tissues, but not all tissues of the body. We hypothesize that undifferentiated Cyno-1 ES cells have deregulated gene expression of imprinted genes and that upon differentiation, imprinted genes in Cyno-1 ES cells become faithful A B C to their parthenogenetic origin. We also hypothesize that a more homogeneous in vivo differentiation of Cyno-1 ES cells can be achieved by modulating the expression of imprinted genes. By characterizing Cyno-1 ES cells at the molecular and cellular level using innovative approaches, we hope to understand the role of gene imprinting in D F EE parthenogenetic primate ES cells during differentiation and development. G H I This new knowledge will be used to obtain parthenogenetic ES cells with the capacity to form all tissues in the body. Eventually, we could develop a model to treat human diseases using these autologous ES cells. If feasible, this could be a unique unlimited source of autologous cells, offering a valid alternative to the ethical and scientific challenges that embryonic stem cells isolated from fertilized embryos pose. Figure 1. Cyno-1 ES cells. Figure 2. Teratoma differentiation of Cyno-1 cells. Tumor in the peritoneal cavity (A), smooth muscle and intestinal epithelia (B), skin (C), intestine (D) hair follicle (E), ganglia (F), melanocytes surrounded by neuronal tissue (G), bone (H) and cartilage (I).